Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

UK MHRA's (Medicines and Healthcare products Regulatory Authority) DES (Device Evaluation Service) updates radiology reviews

This article was originally published in Clinica

Executive Summary

The Device Evaluation Service (DES) of the UK's Medicines and Healthcare products Regulatory Authority (MHRA) has published the third edition of Comparative specifications of single plane cardiovascular imaging systems. It covers the General Electric Innova 2000, Philips Integris Allura Xper FD10, MIS Shimadzu Angiospeed HF, Siemens Axiom Artis dFC, and Toshiba's Infinix CCi and Cci-FPD, among others. The DES' comparative specifications reports aim to assist prospective purchasers in the selection of equipment appropriate to their requirements, but do not contain evaluation data; the DES can supply the related evaluation reports upon request (des@mhra.gsi.gov.uk). As part of its ongoing programme of evaluations of direct digital radiography systems, the DES has published a Digital imaging systems for general radiography report on the General Electric Medical Systems Revolution XR/d2.

Topics

UsernamePublicRestriction

Register

MT054231

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel